Cargando…
Cost-effectiveness of drug-eluting stents versus bare-metal stents in patients undergoing percutaneous coronary intervention
OBJECTIVE: To determine the cost-effectiveness of drug-eluting stents (DES) compared with bare-metal stents (BMS) in patients requiring a percutaneous coronary intervention in France, using a recent meta-analysis including second-generation DES. METHODS: A cost-effectiveness analysis was performed i...
Autores principales: | Baschet, Louise, Bourguignon, Sandrine, Marque, Sébastien, Durand-Zaleski, Isabelle, Teiger, Emmanuel, Wilquin, Fanny, Levesque, Karine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013343/ https://www.ncbi.nlm.nih.gov/pubmed/27621830 http://dx.doi.org/10.1136/openhrt-2016-000445 |
Ejemplares similares
-
Percutaneous coronary intervention causes a rapid but transient mobilisation of CD34(+)CD45(−) cells
por: Padfield, Gareth J, et al.
Publicado: (2014) -
Modified percutaneous coronary intervention-derived risk models (PARIS and CREDO-Kyoto integer scoring systems) applied to Japanese transcatheter aortic valve replacement patients
por: Ohya, Masanobu, et al.
Publicado: (2023) -
Percutaneous coronary intervention in patients with cancer using bare metal stents compared to drug-eluting stents
por: Ahmed, Talha, et al.
Publicado: (2022) -
Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents
por: Faramarzi, Negar, et al.
Publicado: (2013) -
Cost‐effectiveness of percutaneous coronary intervention with cobalt‐chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta‐analysis of randomized trials
por: Ferko, Nicole, et al.
Publicado: (2016)